Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5655.00 | 5959.25 | 0.9489 | 0.8147 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5996.00 | 5959.25 | 1.0062 | 1.0229 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 5889.00 | 5959.25 | 0.9882 | 0.9565 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 5000.00 | 4101.40 | 2776.00 | 5959.25 | 0.4658 | -0.5153 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 3629.00 | 5959.25 | 0.6090 | -0.2031 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 5000.00 | 4101.40 | 3166.00 | 5959.25 | 0.5313 | -0.3814 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 6214.00 | 5959.25 | 1.0427 | 1.1615 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 5000.00 | 4101.40 | 6060.00 | 5959.25 | 1.0169 | 1.0632 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 2829.00 | 5959.25 | 0.4747 | -0.4979 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 5000.00 | 4101.40 | 6003.00 | 5959.25 | 1.0073 | 1.0273 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6025.00 | 5959.25 | 1.0110 | 1.0411 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 5000.00 | 4101.40 | 5744.00 | 5959.25 | 0.9639 | 0.8681 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5925.00 | 5959.25 | 0.9943 | 0.9787 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5874.00 | 5959.25 | 0.9857 | 0.9472 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 3035.00 | 5959.25 | 0.5093 | -0.4280 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 3756.00 | 5959.25 | 0.6303 | -0.1506 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 6068.00 | 5959.25 | 1.0182 | 1.0682 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5426.00 | 5959.25 | 0.9105 | 0.6807 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5858.00 | 5959.25 | 0.9830 | 0.9374 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6143.00 | 5959.25 | 1.0308 | 1.1159 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 6079.00 | 5959.25 | 1.0201 | 1.0752 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5313.00 | 5959.25 | 0.8916 | 0.6164 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5930.00 | 5959.25 | 0.9951 | 0.9818 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 5590.00 | 5959.25 | 0.9380 | 0.7762 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 5835.00 | 5959.25 | 0.9792 | 0.9233 |